ImmuNOA Pte. Ltd.

ImmuNOA Pte. Ltd.

Biotechnology-Research

Company Tagline

Modulating splicing in Immunotherapy

Industry Category
Biotechnology-Research
Company Description

ImmuNOA Pte. Ltd. is a dynamic biotechnology research company dedicated to improving immunotherapy efficacy through innovative approaches. ImmuNOA specializes in the rational design and testing of antisense oligonucleotides to address multiple pathologies, positioning itself as a key player in the future of therapeutic advancements. The company's commitment to cutting-edge research drives its mission to enhance treatment outcomes and expand the possibilities within immunotherapy.

Located at 77 Ayer Rajah Cres, Singapore, 13, SG (Primary address), ImmuNOA is focused on modulating splicing to develop novel therapeutic strategies. By leveraging its expertise in splicing and antisense oligonucleotide technology, ImmuNOA aims to create significant advancements in the field of immunotherapy. The company’s dedication to innovation and scientific rigor ensures its continued growth and impact.

ImmuNOA is constantly pushing the boundaries of biotechnology. With its focus on antisense oligonucleotides and immunotherapy, ImmuNOA is set to revolutionize the treatment of multiple pathologies. We invite the management of ImmuNOA Pte. Ltd. to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.

Key Personnel / Employees
Tommaso Tabaglio Dr. Ervinna Pang PhD CVA (Biotech & Medtech Innovation)

Compare Companies Side by Side

Compare ImmuNOA Pte. Ltd. with 1 companies in Biotechnology-Research

2 Companies
Comparison Field
ImmuNOA Pte. Ltd.
ImmuNOA Pte. Ltd.
Main Company
Alloy Therapeutics, Inc.
Alloy Therapeutics,...
View Profile
Founded Year
2017
Company Size
51-200
City
Boston, Massachusetts
Country
United States
Skills & Keywords Comparing with main company
11 Total Skills
Biotechnology Immunotherapy Antisense Oligonucleotides Splicing Modulation Therapeutic Advancements AON Technology ASO Research Splicing AON Antisense oligonucleotides ASO
12 Total 1 Common 11 Unique
Match 9%
Common Skills:
Biotechnology
Unique Skills:
Biologics Discovery Biotech Bispecific Antibodies Chimeric Antigen Receptors Company Creation Drug Discovery +5
2
Total Companies
2017
Oldest Founded
1
Countries
22
Unique Skills

Similar Companies

Other organizations in the same industry

Mérieux NutriSciences México
Biotechnology-Research

Better Food. Better Health. Better World

Querétaro, Querétaro
Kailera Therapeutics
Biotechnology-Research

Developing therapies for obesity to empower people to transform their lives.

Aktis Oncology
Biotechnology-Research

Realizing the curative power of alpha radiopharmaceuticals for mainstream cancer care.

AmphiStar
Biotechnology-Research

Making Biosurfactants Mainstream

Gent, Vlaanderen
Belgium

Alternative Company Names

This company is also known as

ImmuNOA Pte. Ltd. ImmuNOA私人有限公司 इम्यूनोए प्राइवेट लिमिटेड ImmuNOA بي تي إي. المحدودة ИммуНОА Пте. ООО